Related Experiment Videos
Recent advances in hemophilia. Part V. Discussion paper: Degenerative joint disease
Annals of the New York Academy of Sciences
|January 20, 1975
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
MICA and recovery from hepatitis C virus and hepatitis B virus infections.
Genes and immunity·2004
Long-term FEIBA prophylaxis does not prevent progression of existing joint disease.
Haemophilia : the official journal of the World Federation of Hemophilia·2003
Racial differences in HLA class II associations with hepatitis C virus outcomes.
The Journal of infectious diseases·2001
Relation between HIV-1 and hepatitis C viral load in patients with hemophilia.
Journal of acquired immune deficiency syndromes (1999)·2001
FreqPolyp: Single-Source Domain Generalization for Polyp Segmentation via Amplitude Decoupling and Wavelet Cross-Attention.
Annals of the New York Academy of Sciences·2026
Atypical Inter-Brain Synchrony Network Couples With Behavioral and Linguistic Impairments in Autism Spectrum Disorder.
Annals of the New York Academy of Sciences·2026
Social Connection and Epigenetic Aging: Insights from DNA Methylation Clocks.
Annals of the New York Academy of Sciences·2026
Urea-Predoped, KOH-Activated, Corn Stover-Derived Carbon for CO2 Adsorption.
Annals of the New York Academy of Sciences·2026
ARMOR: Pareto-Aware Dynamic Routing for Energy-Efficient Heterogeneous Multimodal Perception in Autonomous Driving.
Annals of the New York Academy of Sciences·2026
Intra-Islet Paracrine Regulation of Glucagon Secretion During Hypoglycemia, Euglycemia, and Hyperglycemia.
Annals of the New York Academy of Sciences·2026
Association of Time of Day With Functional Outcome in Intracerebral Hemorrhage.
European journal of neurology·2026
Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
A new player in hemolytic uremic syndrome: the plasma kallikrein-kinin system, a target of heme.
Kidney international·2026